Global demand for animal drug compounding is expected to significantly increase, owing to the unavailability of FDA-approved animal drugs. Compounded prescriptions for animal species are considered to be significantly higher than those for branded prescription drugs.
For instance, in 2017, the U.S. FDA estimated that, 75,000 pharmacies in the U.S. fill 6,350,000 animal compounding prescriptions.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12871